Agili-C Implant
-
Regulatory
FDA approves CartiHeal’s Implant for the Treatment of Cartilage and Osteochondral Defects
Approval is based on results of a multicenter, randomized, open-labeled and controlled IDE clinical study that demonstrated the superiority of…
Read More » -
Sports Medicine
CartiHeal Enrolls the 200th Patient in Its Pivotal Clinical Study in San Diego, CA
KFAR SABA, Israel, June 12, 2019 /PRNewswire/ — CartiHeal, developer of the Agili-C™ implant for treating cartilage and osteochondral defects in traumatic and…
Read More » -
Sports Medicine
First Patient in New England Treated With the Agili-C™ Implant at CartiHeal’s Pivotal Study
KFAR SABA, Israel, April 29, 2019 /PRNewswire/ — Christian Lattermann, M.D., Chief of the Sports Medicine Service and Director of the Center for Cartilage…
Read More » -
Extremities
CartiHeal Performs First Agili-C™ Implant Case at The Ohio State University
KFAR SABA, Israel and COLUMBUS, Ohio, Dec. 19, 2018 /PRNewswire/ — CartiHeal, developer of Agili-C, a proprietary implant for the treatment of joint surface lesions, announced…
Read More » -
Sports Medicine
CartiHeal Performs First Agili-C™ Implant Case on the East Coast
NEW YORK and KFAR SABA, Israel, Nov. 12, 2018 /PRNewswire/ — CartiHeal, developer of Agili-C, a proprietary implant for the treatment of joint surface lesions,…
Read More » -
Extremities
CartiHeal’s Agili-C™ Implant Promotes the Regenerative Capacity of Articular Cartilage Defects in Human Cadaveric Ex-vivo Model
KFAR SABA, Israel, Nov. 6, 2018 /PRNewswire/ — CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of joint surface lesions, announced today the…
Read More » -
Extremities
CartiHeal Performs the 100th Agili-C™ Implant Procedure in Italy in the Company’s IDE Multinational Pivotal Study
KFAR SABA, Israel and MILAN, Oct. 25, 2018 /PRNewswire/ — CartiHeal, developer of the proprietary Agili-C implant for the treatment of joint surface lesions, and…
Read More » -
Extremities
CartiHeal Raises $18.3 Million
KFAR SABA, Israel, May 8, 2017 /PRNewswire/ — Funds will support IDE clinical study for company’s Agili-C™ implant CartiHeal (2009)…
Read More »